Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.725
-0.015 (-0.86%)
At close: Feb 27, 2026, 4:00 PM EST
1.730
+0.005 (0.29%)
After-hours: Feb 27, 2026, 7:41 PM EST
Silexion Therapeutics Stock Forecast
SLXN's stock price has decreased by -90% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Silexion Therapeutics stock have an average target of 40.5, with a low estimate of 6.00 and a high estimate of 75. The average target predicts an increase of 2,247.83% from the current stock price of 1.73.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 15, 2025.
Analyst Ratings
The average analyst rating for Silexion Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Litchfield Hills | Litchfield Hills | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +247.83% | Dec 15, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $135 → $75 | Strong Buy | Maintains | $135 → $75 | +4,247.83% | Mar 20, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +7,726.09% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.16
from -395.36
EPS Next Year
-4.48
from -6.16
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.02 | -4.19 | |||
| Avg | -6.16 | -4.48 | |||
| Low | -8.08 | -4.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.